Myriad Genetics
MYGN
#7319
Rank
โ‚ฌ0.47 B
Marketcap
4,98ย โ‚ฌ
Share price
-1.44%
Change (1 day)
-10.85%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): -1,19ย โ‚ฌ

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -1,24ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,59ย โ‚ฌ a decrease over its 2024 EPS that were of -1,29ย โ‚ฌ.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,19ย โ‚ฌ-66.92%
2025-3,59ย โ‚ฌ179.43%
2024-1,29ย โ‚ฌ-55.94%
2023-2,92ย โ‚ฌ130.22%
2022-1,27ย โ‚ฌ275.68%
2021-0,34ย โ‚ฌ-87.99%
2020-2,81ย โ‚ฌ755.56%
2019-0,33ย โ‚ฌ-194.74%
20180,35ย โ‚ฌ-79.89%
20171,72ย โ‚ฌ112.36%
20160,81ย โ‚ฌ-35.97%
20151,27ย โ‚ฌ-7.33%
20141,37ย โ‚ฌ-37.24%
20132,18ย โ‚ฌ59.33%
20121,37ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,46ย โ‚ฌ-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-4,85ย โ‚ฌ 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08204ย โ‚ฌ-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-46,40ย โ‚ฌ 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
34,79ย โ‚ฌ-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA